The DEA Northeast Laboratory (New York, New York) recently received 1,000 off-white, yellowish colored tablets with a light 'G' imprint on one side, suspected 3,4-methylenedioxymethamphetamine (see Photos 14 and 15). The tablets were seized by the Federal Bureau of Investigation, New Jersey Field Office (no further details). Analysis of the tablets (total net mass 829 grams) by color test, GC/FID, GC/MS, FTIR/ATR, and capillary electrophoresis indicated 20.6 milligrams/tablet of methamphetamine, adulterated with dimethylsulfone, caffeine, and procaine hydrochloride (not quantitated). The laboratory routinely analyzes tablets and powders containing methamphetamine. This was an unusual submission due to the high concentration of dimethylsulfone (not quantitated) compared to that of methamphetamine (2.7 %).
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our DEA-licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.